Richard S. Kornbluth

Richard S. Kornbluth, MD, PhD is a founder of Multimeric. The company is based on the FortiVac technology that he invented in collaboration with Geoffrey W. Stone (who was formerly his postdoc at UCSD). Richard is both a basic scientist and a Board-Certified medical internist and pulmonary specialist. During an immunology postdoctoral fellowship at The Scripps Research Institute (TSRI), he filed his first patent on what is now known as CD40 ligand (CD40L). As an Associate Professor at UC San Diego (UCSD), he published more than 50 papers on the immunology and molecular virology of HIV, and wrote or co-wrote 26 funded grant applications. Dr. Kornbluth received a Bachelor’s degree from Harvard College, M.D. from New York Medical College, and Ph.D. in Pathology from Columbia University.